← Back to Influence Map
Entity DossierOrganization
DAIICHI SANKYO, INC.
NJ · US
Global pharmaceutical company.
Tracked direct giving
$0
LDA reported lobbying spend
$2,790,000
Connections
3
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$3.7MTAXTaxation/Internal Revenue Code
$1.9MMMMMedicare/Medicaid
$710KCPTCopyright/Patent/Trademark
$510KPHAPharmacy
$60KTRDTrade
$60KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$2.5M
FARRAGUT PARTNERS LLP$700K
TIBER CREEK GROUP$470K
MARSHALL & POPP, LLC$60K
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | TIBER CREEK GROUP | Hired TIBER CREEK GROUP to lobby on Pharmaceuticals | Source |
| Retained | FARRAGUT PARTNERS LLP | Hired FARRAGUT PARTNERS LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | MARSHALL & POPP, LLC | Hired MARSHALL & POPP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2026) | Source |